Obesity is one of the primary clinical features of Bardet-Biedl Syndrome (BBS), a genetically heterogeneous disorder that is usually inherited as an autosomal recessive trait. It has been suggested that heterozygous carriers of BBS are predisposed to obesity. We set out to identify the common mutation in BBS1 families from southwest Newfoundland and to examine the relationship between this mutation and obesity in the general population.
Introduction
Bardet-Biedl syndrome (BBS: OMIM 209900) is a genetically heterogeneous disorder characterized by obesity, retinal dystrophy, dystrophic extremities, renal structural anomalies and male hypogenitalism. 1 Other clinical features occur with more variability, including learning difficulties, renal failure, diabetes and hypertension. 2 Six BBS genes have been identified: BBS6, 3,4 BBS2, 5 BBS4, 6 BBS1, 7 BBS7 8 and BBS8, 9 and another two BBS loci have been mapped: BBS3 on 3p12-13 10 and BBS5 on 2q31. 11 Several pedigrees appear to be excluded from all known BBS loci, suggesting that another, as yet unmapped, BBS locus exists in the human genome. BBS has usually been modeled as an autosomal recessive trait and it was on this basis that the loci for BBS1-6 were mapped. However, a series of mutational analyses indicates that BBS is inherited, at least in some individuals, in a triallelic manner. 8, [12] [13] [14] This means that two allelic mutations in one BBS gene and a third mutation in another BBS gene are required for the disease phenotype to become manifest. This pattern has also been termed 'recessive inheritance with a modifier of penetrance'. 15 Obesity, from mild to severe, is a cardinal manifestation of BBS patients. It usually begins in early childhood and is progressive with age, 16, 17 although patients are able to regulate their weight through caloric restriction and exercise. In BBS adults, obesity is usually associated with the trunk and proximal limbs and less frequently the face, 18 but it has also been described as diffuse and nonspecific in distribution during early life. 19 Croft et al 20,21 compared affected individuals with obligate carriers and first-degree relatives in BBS families and raised the possibility that BBS heterozygotes are predisposed to obesity. Indeed, they estimated that approximately 3% of all severely overweight white males in the USA carry a single BBS gene. 21 BBS is a relatively rare disorder with a prevalence that varies from one in 125 000 in the United Kingdom 22 to one in 160 000 in Switzerland. 23 The Newfoundland population is enriched for BBS with a prevalence of approximately one in 18 000. 1 The overall increased incidence of BBS in Newfoundland is not due to a single founder effect as shown by the scattered geographic distribution of the families 19, 24 and the contribution of several BBS genes has been described: BBS1; 25,26 BBS2; 12 BBS3; 27 BBS5; 10 and four mutations in BBS6. 3, 12 However, the BBS1 families are primarily grouped in the southwest corner of the island of Newfoundland and a linkage disequilibrium study indicated that they share a common disease-associated haplotype, suggesting a founder effect for BBS1 in Newfoundland. 26 Therefore, we decided to identify the disease-causing mutation in the BBS1 families and to determine if it contributes to obesity in the general population of this region.
Materials and methods

Subjects
Five of the six Newfoundland BBS1 families (B7, B8, B10, B15 and B19) have been described in detail previously, 1, 19, 25, 26 and the sixth (B23) will be documented in a future report. There were eight affected individuals (two male and six female), 37 carriers (16 male and 21 female) and 18 noncarriers (eight male and 10 female) in the family groups. Two groups (an obese cohort and a nonobese cohort) were recruited through advertisements in the local newspaper and the offices of family doctors asking for participation of volunteers. All were 'native Newfoundlanders' who were Caucasians of Northern European ancestry. If an obese or nonobese person was willing to volunteer, he/she was first assessed by a clinical nurse who administered the consent form and the inclusion/exclusion criteria for the study. If he/ she fit the inclusion criteria, he/she was instructed to fill out a standardized questionnaire with regard to demographic variables, diseases related to obesity, drugs, diet and healthcare utilization. The subjects were assessed by a general internist using a comprehensive standardized protocol designed to determine the presence of obesity and comorbid illnesses associated with obesity. All control subjects were examined to ensure that they had no features of a syndromic obesity, such as BBS. Obesity was diagnosed as a body mass index (BMI) 430 kg/m 2 . The control subjects were from the same geographic region (west coast of Newfoundland) and all had a BMI o29 kg/m 2 . Waist to hip ratios were measured as another indicator of obesity as was waist circumference. Characteristics of the 200 volunteers for the obese cohort and the 200 matched controls are shown in Table 1 .
DNA analyses DNA was extracted from whole blood using a simple saltingout method. 28 The mutational screen of the BBS1 gene was performed by direct sequence analysis of PCR amplified products. The primers designed to amplify the BBS1 exons and the corresponding exon/intron boundaries are available upon request from Y Fan. The PCR products were purified with an Exo-SAP cleanup kit (United States Biochemical) and sequencing was carried out using dye-primer chemistry and an ABI 377 automated sequencer. The sequences were analyzed using Sequencher 3.1.1. To screen for the M390R mutation, the BBS1 exon 12 was amplified as described above and subjected to restriction endonuclease digestion with BspHI, which recognizes TCATGA (the wild-type sequence) but not TCAGGA (the T to G mutation is highlighted). The electrophoretic fragment patterns corresponding to a homozygous wild type, a heterozygous carrier, and a homozygous M390R mutant are shown in Figure 1b . All M390R alleles were confirmed by DNA sequencing (Figure 1a ).
Results
BBS1 mutation in the Newfoundland population
Haplotype analysis had previously indicated that five of the Newfoundland BBS families (B7, B8, B10, B15 and B19) were consistent with linkage to BBS1. 24, 26 Segments that covered all exons and exon/intron boundaries of the BBS1 gene were amplified from the DNA of an affected individual from each BBS1 family. DNA sequencing revealed a single mutation, namely, a T to G in exon 12 that caused an amino-acid change (M390R), in the homozygous state in each affected individual ( Figure 1a ). This is a common missense mutation in BBS1 and accounts for approximately 80% of all known BBS1 mutations.
29
Obesity and genotype in BBS1 families Members of the six BBS1 families were analyzed for the presence of the M390R mutation and categorized as affected, carrier or noncarrier. The BMIs of each group are shown in Figure 2 . The affected individuals (n ¼ 7) are more obese than ; average waist to hip ratio ¼ 0.896; average waist circumference ¼ 86.9 cm) from southwest Newfoundland, the region where most of the BBS1 families come from. Three of the 200 obese individuals were heterozygous for the M390R mutation compared with three carriers of this mutation in the 200 controls. Clinical information on these six individuals is presented in Table 2 . It appears that there is no difference in the distribution of the M390R BBS1 mutation between obese and nonobese individuals in this population. The estimated frequency of the M390R allele in this part of Newfoundland is 0.0075 (ie six M390R alleles in 800 chromosomes tested).
Discussion
Obesity, as measured by BMI, waist to hip ratio or waist circumference, is an excellent example of a quantitative phenotype that is controlled by many different genes and further influenced by environmental variables. The heritability of obesity has been estimated to lie between 50 and 90% with a relatively minor role being played by cultural transmission. 30 Three main genetic approaches to the study of obesity in humans have been adopted: (a) genome-wide scans to identify quantitative trait loci (QTL); (b) the study of specific genes based on candidates identified from animal models; and (c) the study of syndromes that have obesity as one of their characteristics and which exhibit a Mendelian pattern of inheritance. The results of these studies are reviewed annually in the form of a human obesity gene map and the latest update of results through October 2002 includes 68 human QTL for obesity and 33 Mendelian syndromes relevant to human obesity. 31 The QTL and
Mendelian approaches do not appear to have a significant overlap and it is intriguing to speculate to what extent syndromes with an obesity component, such as BBS, contribute to obesity in the general population. It had been suggested previously that carriers of a BBS mutation are predisposed to obesity. 20, 21 The Newfoundland population as a whole has an increased incidence of BBS, 24 which is not the result of a single founder effect, and this has been called the 'Newfoundland Paradox'. 32 It has been proposed that one of the reasons for this increase of BBS in the Newfoundland population is past selection for an increased capacity for carriers of a BBS mutation (heterozygoytes) to store fat under adverse environmental conditions. 33 There is evidence to suggest that a founder effect was responsible for the Newfoundland families with BBS1. 26 Therefore, we set out to determine if carriers of BBS1 are in fact more prone to obesity and if there is a greater frequency of BBS1 mutant alleles in the obese members of the population. Along with the increased regional prevalence of BBS1, the other major advantage in testing this hypothesis in the west coast of Newfoundland is the amplified signal to noise ratio. In association studies for complex diseases, the ability to detect a relevant association may be constrained by the background noise of the population under study. Therefore, unless large cohorts are assembled, a modest genetic signal may be overlooked. The Newfoundland population, with relative genetic and environmental homogeneity, may offer opportunities for finding such modest signals. 34 Estimates for the power of this study were obtained using Epi6 statistical software (v. 6.04b, 1997). Assuming equal numbers (200) in each group of unrelated individuals defined as either obese or nonobese across all baseline frequencies in one group we estimate 80% power of detecting associations for allele frequency differences of at least 10% in the other group, with statistical significance P ¼ 0.05. For very low baseline frequencies in one group, allele frequency differences somewhat less than 10% can also reach statistical significance. This is a favorable estimate in light of the initial allele frequency difference of 20% seen among type II diabetes groups that eventually led to the identification of the proposed susceptibility gene, calpain-10. 35 Certainly, any increases above 200 in each patient group are expected to improve the power of the study, and any opportunities for increasing the collection will be considered. Our results identified a common mutation, M390R, in six BBS1 Newfoundland families. Heterozygous individuals were not significantly more obese than noncarriers of the mutation in these families and this is similar to the observation in a survey of British BBS families. 2 Moreover, there was no difference in the frequency of the M390R mutation in obese and nonobese volunteers. Therefore, we conclude that the M390R BBS1 mutation does not make any significant contribution to obesity in the general population of Newfoundland.
